子類別 期刊論文 [100/101] 會議論文/會議摘要 [19/24] 鄰近社群 于重元 [19/19] 劉柯俊 [85/98] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群統計 近3年內發表的文件:16(12.80%) 含全文筆數:119(95.20%) 文件下載次數統計 下載大於0次:119(100.00%) 下載大於100次:115(96.64%) 檔案下載總次數:64420(1.20%) 最後更新時間: 2024-12-01 03:13 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Taiwan nationwide study of first-li... Survival of advanced/recurrent gast... Impact of pathological nodal stagin... Prevalence of comorbidities and the... Association of smoking and ALK tyro... Carbohydrate antigen 19-9 response ... Adjuvant chemotherapy compared with... Secular trends of clinical characte... Optimizing margin status for improv... Overall survival in the OlympiA pha...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 125. (共5頁) 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-10-11	Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma	Targeted Oncology. 2024 Oct 11;Article in Press.
2024-07-11	Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study	BMC Cancer. 2024 Jul 11;24:Article number 828.
2023-10	Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer	Lung Cancer. 2023 Oct;184:Article number 107357.
2023-09	Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study	International Journal of Radiation Oncology Biology Physics. 2023 Sep 1;117(1):74-86.
2023-04-25	Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study	Scientific Reports. 2023 Apr 25;13:Article number 6727.
2023-03-17	Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naive ALK-positive advanced lung adenocarcinoma	Frontiers in Oncology. 2023 Mar 17;13:Article number 1063695.
2023-02-28	Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma	Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683.
2022-12-31	Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019	Viruses. 2022 Dec 31;15(1):Article number 126.
2022-12	Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan	Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218.
2022-12	Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer	Annals of Oncology. 2022 Dec;33(12):1250-1268.
2022-11-14	Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals	Frontiers in Oncology. 2022 Nov 14;12:Article number 1019555.
2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	European Journal of Cancer. 2022 Sep;173:123-132.
2022-07	Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors	Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
2022-03-01	Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018	JAMA Network Open. 2022 Mar 1;5(3):Article number e224830.
2022-02-01	A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
2022-02	Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps	Annals of Surgical Oncology. 2022 Feb;29(2):1130-1140.
2021-11-30	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Scientific Reports. 2021 Nov 30;11:Article number 23142.
2021-07	Atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma and chronic hepatitis B virus infection with high viral load	Annals of Oncology. 2021 Jul;32(Suppl. 3):S141-S142.
2021-05-26	Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis	Oral Oncology. 2021 May 26;119:Article number 105358.
2021-05-20	Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer	Cancers. 2021 May 20;13(10):Article number 2494.
2021-05	High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Radiotherapy and Oncology. 2021 May;158:146-154.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2021-02-04	Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up	Journal of Clinical Oncology. 2021 May;39(13):1448-1457.
2020-07-01	A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue	Haematologica. 2020 Jul 1;105(7):e349-e354.
2020-05	An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas	Oncologist. 2020 May;25(5):e782-e788.

顯示項目1-25 / 125. (共5頁) 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目